• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异基因骨髓移植后供体细胞中白血病复发的发生率。

The incidence of recurrence of leukemia in donor cells after allogeneic bone marrow transplantation.

作者信息

Boyd C N, Ramberg R C, Thomas E D

出版信息

Leuk Res. 1982;6(6):833-7. doi: 10.1016/0145-2126(82)90067-4.

DOI:10.1016/0145-2126(82)90067-4
PMID:6759797
Abstract

A total of 243 patients with acute leukemia received a marrow graft from a donor of the opposite sex. Seventy-five patients subsequently relapsed, and specimens of the recurrent leukemia cells were available for cytogenetic analysis in 54. Three relapses were in donor-type cells. Four patients whose relapses were in host-type cells showed a cytogenic abnormality that differed from the original leukemic clone. We conclude that a 'new' leukemia in donor cells, and possibly in host cells, constitutes a small but significant fraction of recurrent leukemia after marrow grafting.

摘要

共有243例急性白血病患者接受了来自异性供体的骨髓移植。75例患者随后复发,其中54例有复发性白血病细胞标本可供细胞遗传学分析。3例复发为供体型细胞。4例复发为宿主型细胞的患者显示出与原始白血病克隆不同的细胞遗传学异常。我们得出结论,供体细胞中,可能还有宿主细胞中的“新”白血病,在骨髓移植后复发性白血病中占一小部分但比例显著。

相似文献

1
The incidence of recurrence of leukemia in donor cells after allogeneic bone marrow transplantation.异基因骨髓移植后供体细胞中白血病复发的发生率。
Leuk Res. 1982;6(6):833-7. doi: 10.1016/0145-2126(82)90067-4.
2
Recurrence of acute leukemia more than two years after allogeneic marrow grafting.异基因骨髓移植两年多后急性白血病复发。
Exp Hematol. 1986 Mar;14(3):178-81.
3
Transfusion of donor buffy coat cells in the treatment of persistent or recurrent malignancy after allogeneic bone marrow transplantation.输注供体富含白细胞层细胞治疗异基因骨髓移植后持续或复发的恶性肿瘤。
Transfusion. 1995 Nov-Dec;35(11):891-8. doi: 10.1046/j.1537-2995.1995.351196110891.x.
4
Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation.非格司亭治疗异基因骨髓移植后白血病和骨髓增生异常综合征复发的初步结果。
N Engl J Med. 1993 Sep 9;329(11):757-61. doi: 10.1056/NEJM199309093291103.
5
Transfusion of donor peripheral blood buffy coat cells as effective treatment for relapsed acute leukemia after transplantation of allogeneic bone marrow or peripheral blood stem cells from the same donor.输注供体外周血 Buffy 层细胞作为同一供体异基因骨髓或外周血干细胞移植后复发急性白血病的有效治疗方法。
Transfusion. 1996 Aug;36(8):685-90. doi: 10.1046/j.1537-2995.1996.36896374371.x.
6
Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation.供体白细胞输注用于异基因骨髓移植后复发的慢性髓性白血病。
J Clin Oncol. 1993 Mar;11(3):513-9. doi: 10.1200/JCO.1993.11.3.513.
7
High frequency of extramedullary relapse of acute leukemia after allogeneic bone marrow transplantation.异基因骨髓移植后急性白血病髓外复发的高频率。
Bone Marrow Transplant. 2000 Jul;26(2):147-52. doi: 10.1038/sj.bmt.1702488.
8
Filgrastim for the treatment of leukemia relapse after bone marrow transplantation.非格司亭用于治疗骨髓移植后白血病复发。
Bone Marrow Transplant. 1996 Oct;18(4):817-9.
9
Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.用于治疗骨髓移植后复发的异基因外周血祖细胞。
Bone Marrow Transplant. 1997 Oct;20(7):533-41. doi: 10.1038/sj.bmt.1700934.
10
Recurrent isolated extramedullary relapses as granulocytic sarcomas following allogeneic bone marrow transplantation for acute myeloid leukemia.
Bone Marrow Transplant. 1998 Jan;21(2):205-8. doi: 10.1038/sj.bmt.1701043.

引用本文的文献

1
A case report of donor cell-derived hematologic neoplasms 9 years after allogeneic hematopoietic cell transplantation.异基因造血细胞移植9年后供体细胞来源血液系统肿瘤的病例报告
Oncotarget. 2025 Feb 5;16:44-50. doi: 10.18632/oncotarget.28686.
2
Donor Cell-Derived Myelodysplastic Syndrome Following Allogenic Peripheral Blood Stem Cell Transplant.异基因外周血干细胞移植后供体细胞来源的骨髓增生异常综合征
Int J Hematol Oncol Stem Cell Res. 2023 Apr 1;17(2):125-127. doi: 10.18502/ijhoscr.v17i2.12651.
3
Clinical considerations at the intersection of hematopoietic cell transplantation and hereditary hematopoietic malignancy.
造血细胞移植与遗传性造血系统恶性肿瘤交叉领域的临床考量
Front Oncol. 2023 May 12;13:1180439. doi: 10.3389/fonc.2023.1180439. eCollection 2023.
4
Anti-CD19 chimeric antigen receptor T-cell followed by interferon-α therapy induces durable complete remission in donor cell-derived acute lymphoblastic leukemia: A case report.抗CD19嵌合抗原受体T细胞继以干扰素-α治疗诱导供体细胞来源的急性淋巴细胞白血病持久完全缓解:一例报告
Front Oncol. 2022 Nov 24;12:1021786. doi: 10.3389/fonc.2022.1021786. eCollection 2022.
5
Lessons Learned from Donor Cell-Derived Myeloid Neoplasms: Report of Three Cases and Review of the Literature.供体细胞源性髓系肿瘤的经验教训:三例报告及文献综述
Life (Basel). 2022 Apr 8;12(4):559. doi: 10.3390/life12040559.
6
Far from Health: The Bone Marrow Microenvironment in AML, A Leukemia Supportive Shelter.远离健康:急性髓系白血病中的骨髓微环境——白血病的支持性庇护所
Children (Basel). 2021 May 8;8(5):371. doi: 10.3390/children8050371.
7
Jumping translocations of 1q in donor cell-derived myelodysplastic syndrome after cord blood transplantation: Case report and review of the literature.脐血移植后供体细胞来源的骨髓增生异常综合征中1q的跳跃易位:病例报告及文献复习
Mol Clin Oncol. 2020 Apr;12(4):365-373. doi: 10.3892/mco.2020.1995. Epub 2020 Feb 6.
8
Stem cell donors should be screened for CHIP.供者干细胞应进行 CHIP 筛查。
Blood Adv. 2020 Feb 25;4(4):784-788. doi: 10.1182/bloodadvances.2019000394.
9
Backtracked analysis of preleukemic fusion genes and DNA repair foci in umbilical cord blood of children with acute leukemia.急性白血病患儿脐带血中白血病前期融合基因与DNA修复灶的回溯性分析
Oncotarget. 2018 Apr 10;9(27):19233-19244. doi: 10.18632/oncotarget.24976.
10
Post-Transplantation Cyclophosphamide after Bone Marrow Transplantation Is Not Associated with an Increased Risk of Donor-Derived Malignancy.骨髓移植后使用移植后环磷酰胺与供者来源恶性肿瘤风险增加无关。
Biol Blood Marrow Transplant. 2017 Apr;23(4):612-617. doi: 10.1016/j.bbmt.2016.12.640. Epub 2017 Jan 3.